Discover trends, market shifts, and competitive outlooks for the peptide antibiotics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Projected Market Size and Growth Rates for the Peptide Antibiotics Market From 2025 To 2029?
There’s been a significant expansion in the peptide antibiotics market in the past few years. The market, which was valued at $5.25 billion in 2024, is expected to see a rise to $5.82 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.8%. Factors that contributed to this growth during the historical period include the discovery and enhancement of peptide antibiotics, a surge in antibiotic resistance, an increase in infectious diseases incidence, advancements in peptide synthesis technologies, and the overall expansion of the pharmaceutical industry.
Expectations indicate that the peptide antibiotics market will experience significant growth in the coming years. The market size is projected to reach $8.47 billion by 2029, with an annual compound growth rate (CAGR) of 9.8%. This growth during the forecast period can be attributed to factors such as the heightened focus on the creation of new antibiotics, the increase in global cases of antibiotic-resistant infections, the expansion of research and development in the field of antimicrobial peptides, and regulatory support for the approval of new antibiotics. Some major trends seen in the forecast period are the exploration of natural sources for antimicrobial peptides, the use of peptide antibiotics for animal health, targeted peptide engineering to improve effectiveness, the development of combination peptide antibiotics, as well as the introduction of artificial intelligence and machine learning into the discovery of peptide antibiotics.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Peptide Antibiotics Market?
The surge in the occurrence of numerous infectious diseases is predicted to drive the expansion of the peptide antibiotics market. These diseases are instigated by harmful pathogens such as bacteria, fungi, parasites, among others. The escalation in infectious illnesses is primarily due to swift urbanization, climate modifications, heightened risk of disease surge, and so on, leading to a heightened need for peptide antibiotics. These antibiotics function by physically breaking the cell membranes, bolstering their antibacterial action. For instance, as reported by the World Health Organization, a Switzerland-based intergovernmental organization, by May 2024 the dengue cases in the America region had already crossed seven million by April 2024, a number that greatly surpasses the 4.6 million cases reported throughout 2023. Hence, the increase in infectious disease cases is fueling the growth of the peptide antibiotics market.
Which Primary Segments of the Peptide Antibiotics Market Are Driving Growth and Industry Transformations?
The peptide antibiotics market covered in this report is segmented –
1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels
Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Peptide Antibiotics Market?# Market?
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Most Significant Market Trends in the Peptide Antibiotics Market?
A significant trend emerging in the peptide antibiotics market is the formation of strategic partnerships. Many key players in the market are seeking out collaborations to enhance their market presence and optimize resource utilization. For instance, USA’s digital cell biology firm, Berkeley Lights, formed a partnership with Aanika Biosciences in January 2022. This collaboration will enable Aanika to utilize Berkeley Lights’ robust, high-throughput screening service to swiftly pinpoint and fine-tune functional antimicrobial peptides (AMPs) that can wipe out hazardous bacteria, specifically those that trigger foodborne illness outbreaks. In addition, the Beacon Optofluidic Platform will be instrumental in identifying bacteria-threatening peptides to create a unique antibacterial tag. This tag will subsequently be incorporated in Aanika Biosciences’ bacterial spore-based barcoding technology to ensure food supply chain safety. Aanika Biosciences is a biotechnology firm based in the USA.
View the full report here:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report
What Parameters Are Used to Define the Peptide Antibiotics Market?
Peptide antibiotics refer to antibiotics made up of peptides the physical rupture of cell membranes underpins the antibacterial activity. The peptide antibiotics are used to permeate bacterial membranes, collect within bacteria, and then interfere with bacterial functioning.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
